Table 1.
Histology | Method | Cases | % cases | Authors (References) |
---|---|---|---|---|
Cervical scc | IHC | ≧ 1 (98) | ≧ 1 (96.1%) | Wu et al. [39]* |
≧ 2 (82) | ≧ 2 (80.4%) | |||
Lung SCC | IHC | 47.90% | Wang et al. [41]** | |
HNSCC | IHC | 100% | Adams et al. [46]*** | |
OSCC | IHC | 88% | Nakashima et al. [19]**** |
*Immunostaining was zero (negative), or < 5% positive cells; one (weak positive), 5–25% positive cells; two (intermediate positive), 26–50% positive cells; three (strong positive), > 50% positive cells. Only nuclear expression was considered as positive staining
**Intensity of DEK nuclear staining was also scored as zero (no staining), one (weak), or two (marked). Percentage scores were assigned as one (1–25%), two (26–50%), three (51–75%), and four (76–100%). The scores were multiplied to give a final score of 0–8, and the total expression of DEK was determined as either negative or low expression (− ; score < 4) or overexpression (+ ; score ≥ 4)
***Number of cells with positive staining was quantified as: three (≥ 90% positive tumor cells), two (10–50% positive tumor cells), or one (< 10% positive tumor cells). The intensity of DEK staining was determined as W (weak), V (variable), or S (strong)
****Number of cells with positive staining scored as: one (0–25%), two (26–50%), three (51–75%), and four (76–100%). The expression of DEK was determined as either negative or low expression (1–2) or overexpression (3–4)